Unbuzzd Wellness Inc., backed by Quantum BioPharma, appointed Richard Buzbuzian as CEO to spearhead the nationwide commercialization of unbuzzd™, a clinically validated beverage that accelerates alcohol metabolism and reduces hangover symptoms. The company plans to expand first into South Florida and Texas, targeting the $198 billion functional beverage market with a clean-label, science-backed product. Unbuzzd combines hydration and hangover relief in a ready-to-mix powder, supported by a peer-reviewed clinical study. The strategy includes multi-channel retail and e-commerce distribution, aiming for a stock exchange listing and further product line expansion.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Thor Explorations produced 19,153 ounces of gold in Q2 2026 from its Segilola mine in Nigeria, maintaining its full-year production guidance of 75,000 to 85,000 ounces. The company generated $77.3 million in revenue by selling 17,050 ounces at an ave...
Angelini Pharma has finalized its $4.1 billion acquisition of Catalyst Pharmaceuticals, enhancing its footprint in the U.S. market and strengthening its global leadership in brain health and rare diseases. The deal includes significant investments fr...
Zcash (ZEC) has gained over 16% in the past week, rallying from lows near $368 to around $552 following an 11% jump in one session. This surge is driven by anticipation of the Ironwood shielded pool upgrade expected around July 28, which addresses a ...
Greenwich LifeSciences is developing GLSI-100, an immunotherapy targeting HER2-positive breast cancer, currently in Phase 3 trials. The drug showed a 70-80% reduction in cancer recurrence in Phase 2b, outperforming existing treatments with no serious...
